Press Releases

Press Releases

    Date Title View
    05/16/19
    Summary ToggleHorizon Therapeutics plc Launches New Data-Driven Campaign to Reset the Dialogue on Gout
    PDF Version
    05/09/19
    Summary ToggleHorizon Therapeutics plc Announces Tina Ventura as a Healthcare Businesswomen's Association 2019 Luminary
    PDF Version
    05/08/19
    Summary ToggleHorizon Therapeutics plc Reports Strong First-Quarter 2019 Results; Increases Full‐Year 2019 Net Sales and Adjusted EBITDA Guidance
    05/06/19
    Summary ToggleHorizon Therapeutics plc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    PDF Version
    04/26/19
    Summary ToggleNew Data from Phase 3 Teprotumumab Trial (OPTIC) Shows Dramatic Reduction in Proptosis, or Eye Bulging, the Main Cause of Morbidity in Active Thyroid Eye Disease (TED)
    PDF Version
    04/16/19
    Summary ToggleHorizon Pharma plc and Gift of Adoption Announce a New Fund to Facilitate Global Adoptions of Children with Rare Diseases
    PDF Version
    04/12/19
    Summary ToggleHorizon Pharma plc to Present Results from its Phase 3 Teprotumumab Trial (OPTIC) at the 2019 American Association of Clinical Endocrinologists (AACE) Scientific and Clinical Congress
    PDF Version
    04/11/19
    Summary ToggleHorizon Pharma plc Named One of the 2019 Best Workplaces in Health Care and Biopharma by FORTUNE and Great Place to Work®
    PDF Version
    04/09/19
    Summary ToggleHorizon Pharma plc to Release First-Quarter 2019 Financial Resultsand Host Webcast on May 8, 2019
    PDF Version
    04/04/19
    Summary ToggleHorizon Pharma plc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    PDF Version
    Displaying 1 - 10 of 435 results